TNFSF9, a type II transmembrane glycoprotein and member of the TNF superfamily, preferentially expressed by B cells, acts as a ligand for CD137 (4-1BB ligand receptor/TNFRSF9).
Interaction between 4-1BBL and its receptor acts as a co-stimulatory signal for T cell activation and expansion, and is involved in the generation of cytotoxic T cells (Tc) and in the process of antigen presentation. Expression of 4-1BBL by a variety of carcinoma cells, suggests a role for 4-1BBL in tumor cell-T cell interactions.
Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.
Recommended Dilution:
ELISA: 0.25-1ug/ml
Western Blot: 0.1-0.2ug/ml
Optimal dilutions to be determined by the researcher.
Recommended Secondary Antibodies:
Streptavidin APC
Streptavidin FITC
Streptavidin TRITC
Streptavidin RPE, RPE
Streptavidin HRP
Streptavidin Alk. Phos.
Storage and Stability:
Lyophilized powder may be stored at-20 degrees C. Stable for 12 months at -20 degrees C. Reconstitute with 0.5ml sterile PBS containing 0.1% BSA. Aliquot and store at -20 degrees C. Reconstituted product is stable for 6 months at -20 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.